Protagonist Therapeutics: Q1 Earnings Snapshot
By Ap News
Published - May 07, 2024, 04:28 PM ET
Last Updated - May 07, 2024, 04:28 PM EDT
NEWARK, Calif. (AP) — NEWARK, Calif. (AP) — Protagonist Therapeutics Inc. (PTGX) on Tuesday reported first-quarter net income of $207.3 million.
The Newark, California-based company said it had net income of $3.26 per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $2.51 per share.
The biopharmaceutical company posted revenue of $255 million in the period.
